Portal de recerca
ESTUDIO ABIERTO PROSPECTIVO, MULTICENTRICO SOBRE LA EFICACIA, FARMACOCINETICA, SEGURIDAD Y TOLERABILIDAD DE UNA INMUNOGLOBULINA SUBCUTANEA (HUMANA) 16%, POLIVALENTE, PASTEURIZADA, LIQUIDA (CE1200) EN INDIVIDUOS AFECTOS DE INMUNODEFICIENCIA PRIMARIA (PID).
Dades bàsiques
- Protocol:
- CE1200_3002
- EURDRACT:
- NO PROCEDE
- NCT:
- Centre:
- Any inici:
- Any de finalització:
Documents
- No hi ha documents
Participants
Finançadors - Promotors
FUJISAWA GMBH
Resultats de l'Assaig Clínic
Actualización de las recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (COVID-19) en pacientes con trasplante renal.
López V; (...); Hernández D
Article. 10.1016/j.nefro.2022.11.001. 2023
An ultra-sensitive homologous chemiluminescence immunoassay to tackle penicillin allergy.
Quintero-Campos P; (...); Morais S
Article. 10.1016/j.aca.2022.339940. 2022
Characterization of anaphylaxis reveals different metabolic changes depending on severity and triggers
Perales-Chorda C; (...); de Rojas, DHF
Article. 10.1111/cea.13991. 2021
Hereditary angioedema due to C1 inhibitor deficiency: real-world experience from the Icatibant Outcome Survey in Spain.
Guilarte M; (...); IOS Study Group
Article. 10.1186/s13223-021-00641-3. 2021
Live donor kidney transplantation. Situation analysis and roadmap.
de la Oliva Valentín M; (...); Domínguez-Gil B
Article. 10.1016/j.nefroe.2022.02.002. 2022
Multiplexed analytical approaches to beta-lactam allergy in vitro testing standardization
Juarez, MJ; (...); Morais, S
Article. 10.1016/j.aca.2021.338656. 2021
Tubulo-interstitial inflammation increases the risk of graft loss after the recurrence of IgA nephropathy
Rodrigo E; (...); Hernández D
Article. 10.1093/ckj/sfad259. 2024